Jpmorgan Chase & CO Pa Vmed Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.5 $21 - $48	97 Added 38.8%	347 $0
Q2 2022 Aug 11, 2022	SELL	$0.85 - $1.41 $28,973 - $48,061	-34,086 Reduced 99.27%	250 $0
Q1 2022 May 11, 2022	BUY	$1.16 - $2.5 $8,767 - $18,895	7,558 Added 28.22%	34,336 $45,000
Q3 2021 Nov 12, 2021	BUY	$5.1 - $9.39 $136,567 - $251,445	26,778 New	26,778 $229,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.